Swedish Orphan Biovitrum AB - Company & Market Research Reports

Sobi is a leading integrated biopharmaceutical company that focuses on developing therapies and treatments for haemophilia, inflammation, genetic and metabolic diseases. Its operations are split into three core areas: Core Products, Partner Products and ReFacto Manufacturing. The organisation spans 24 countries, delivering therapies to patients in 67 countries across the globe. However, Europe accounts for up to 54 per cent of its sales. Sobi is headquartered in Stockholm, Sweden.


Mucopolysaccharidosis III (Sanfilippo syndrome) Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments - Product Thumbnail Image

Mucopolysaccharidosis III (Sanfilippo syndrome) Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Report
  • 89 Pages
From
Gouty Arthritis (Gout) - Pipeline Review, H1 2018 - Product Thumbnail Image

Gouty Arthritis (Gout) - Pipeline Review, H1 2018

  • Report
  • 99 Pages
From
Global Autoimmune and Inflammatory Immunomodulators Market 2016-2020 - Product Thumbnail Image

Global Autoimmune and Inflammatory Immunomodulators Market 2016-2020

  • Report
  • 98 Pages
From
Global Rheumatoid Arthritis Market Analysis 2016 - Forecast to 2022 - Product Thumbnail Image

Global Rheumatoid Arthritis Market Analysis 2016 - Forecast to 2022

  • Report
  • 134 Pages
From
Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2021 - Novel IL-6 and JAK Inhibitors to Stimulate Moderate Growth Despite Brand Erosion of Blockbuster Anti-TNFs - Product Thumbnail Image

Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2021 - Novel IL-6 and JAK Inhibitors to Stimulate Moderate Growth Despite Brand Erosion of Blockbuster Anti-TNFs

  • Report
  • 126 Pages
From
Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) - Pipeline Review, H1 2016 - Product Thumbnail Image

Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) - Pipeline Review, H1 2016

  • Report
  • 141 Pages
From
Ulcerative Colitis - Pipeline Review, H1 2018 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Review, H1 2018

  • Report
  • 482 Pages
From
Global Hemophilia Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025 - Product Thumbnail Image

Global Hemophilia Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • Report
From
World Hemophilia Treatment Market - Opportunities and Forecasts, 2017 - 2023 - Product Thumbnail Image

World Hemophilia Treatment Market - Opportunities and Forecasts, 2017 - 2023

  • Report
From
Global Factor VIII Deficiency Treatment Market 2017-2021 - Product Thumbnail Image

Global Factor VIII Deficiency Treatment Market 2017-2021

  • Report
  • 70 Pages
From
Global Hemophilia Drugs Market 2016-2020 - Product Thumbnail Image

Global Hemophilia Drugs Market 2016-2020

  • Report
  • 84 Pages
From
Global Hemophilia Therapeutics Market By Drug, By Type of Hemophilia, By Treatment, By Therapy Outlook 2022 - Product Thumbnail Image

Global Hemophilia Therapeutics Market By Drug, By Type of Hemophilia, By Treatment, By Therapy Outlook 2022

  • Report
  • 95 Pages
From
Factor IX -Pipeline Insight, 2018 - Product Thumbnail Image

Factor IX -Pipeline Insight, 2018

  • Drug Pipelines
  • 60 Pages
From
Competitor Analysis: Coagulation Factors - Product Thumbnail Image

Competitor Analysis: Coagulation Factors

  • Report
  • 158 Pages
From
Coagulation Factors 2010 - The Portfolio Aspect as Decisive Force: A Competitive Landscape and R&D Pipeline Analysis of Hemostasis Proteins - Product Thumbnail Image

Coagulation Factors 2010 - The Portfolio Aspect as Decisive Force: A Competitive Landscape and R&D Pipeline Analysis of Hemostasis Proteins

  • Report
  • 446 Pages
From
Oral Mucositis Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Oral Mucositis Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 179 Pages
From
Mucositis Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Mucositis Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 107 Pages
From
N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H1 2018 - Product Thumbnail Image

N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H1 2018

  • Report
  • 48 Pages
From
N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H2 2017 - Product Thumbnail Image

N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H2 2017

  • Report
  • 48 Pages
From
Global Immunology Drugs Market to 2022 - Increasing Prevalence, Repositioning Opportunities and Strong Uptake of Interleukin Receptor Inhibitors to Drive Growth - Product Thumbnail Image

Global Immunology Drugs Market to 2022 - Increasing Prevalence, Repositioning Opportunities and Strong Uptake of Interleukin Receptor Inhibitors to Drive Growth

  • Report
  • 140 Pages
From
Loading Indicator
adroll